Iain F Brew1, Christine Butt2, Nat Wright3. 1. In hepatitis C; Clinical director of Leeds Prison Healthcare Department, HMP Leeds, Leeds. 2. Clinical research fellow, Clinical director of Leeds Prison Healthcare Department, HMP Leeds, Leeds. 3. Clinical director of Leeds Prison Healthcare Department, HMP Leeds, Leeds.
Abstract
BACKGROUND: The burden of hepatitis C (HCV) treatment is growing, as is the political resolve to tackle the epidemic. Primary care will need to work more closely with secondary care to succeed in reducing the prevalence of chronic HCV. AIM: To identify research relating to the provision of antiviral treatment for HCV in primary care. DESIGN AND SETTING: A narrative systematic review of six databases. Method Medline, Embase, Cinahl, PsycINFO, Web of Science, and Cochrane were searched. Relevant journals were searched by hand for articles to be included in the review. Reference lists of relevant papers were reviewed and full-text papers were retrieved for those deemed to potentially fulfil the inclusion criteria of the review. RESULTS: A total of 683 abstracts led to 77 full-text articles being retrieved, of which 16 were finally included in the review. An evidence base emerged, highlighting that community-based antiviral treatment provision is feasible and can result in clinical outcomes comparable to those achieved in hospital outpatient settings. Such provision can be in mainstream general practice, at community addiction centres, or in prisons. GPs must be trained before offering such a service and there is also a need for ongoing specialist supervision of primary care practice. Such training and supervision can be delivered by teleconference, although, even with such ready availability of training and supervision, only a minority of GPs are likely to want to provide antiviral treatment. CONCLUSION: There is emerging evidence supporting the effectiveness of antiviral treatment provision for patients with chronic hepatitis C in a wide variety of primary care and wider community settings. Training and ongoing supervision of primary care practitioners by specialists is a prerequisite. There is an opportunity through future research activity to evaluate typologies of patients who would be best served by primary care-based treatment and those for whom hospital-based outpatient treatment would be most appropriate.
BACKGROUND: The burden of hepatitis C (HCV) treatment is growing, as is the political resolve to tackle the epidemic. Primary care will need to work more closely with secondary care to succeed in reducing the prevalence of chronic HCV. AIM: To identify research relating to the provision of antiviral treatment for HCV in primary care. DESIGN AND SETTING: A narrative systematic review of six databases. Method Medline, Embase, Cinahl, PsycINFO, Web of Science, and Cochrane were searched. Relevant journals were searched by hand for articles to be included in the review. Reference lists of relevant papers were reviewed and full-text papers were retrieved for those deemed to potentially fulfil the inclusion criteria of the review. RESULTS: A total of 683 abstracts led to 77 full-text articles being retrieved, of which 16 were finally included in the review. An evidence base emerged, highlighting that community-based antiviral treatment provision is feasible and can result in clinical outcomes comparable to those achieved in hospital outpatient settings. Such provision can be in mainstream general practice, at community addiction centres, or in prisons. GPs must be trained before offering such a service and there is also a need for ongoing specialist supervision of primary care practice. Such training and supervision can be delivered by teleconference, although, even with such ready availability of training and supervision, only a minority of GPs are likely to want to provide antiviral treatment. CONCLUSION: There is emerging evidence supporting the effectiveness of antiviral treatment provision for patients with chronic hepatitis C in a wide variety of primary care and wider community settings. Training and ongoing supervision of primary care practitioners by specialists is a prerequisite. There is an opportunity through future research activity to evaluate typologies of patients who would be best served by primary care-based treatment and those for whom hospital-based outpatient treatment would be most appropriate.
Authors: John Farley; Shawn Vasdev; Benedikt Fischer; Emma Haydon; Jürgen Rehm; Theresa A Farley Journal: Am J Public Health Date: 2005-08-30 Impact factor: 9.308
Authors: Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill Journal: Clin Infect Dis Date: 2005-04-15 Impact factor: 9.079
Authors: Scott A Allen; Anne C Spaulding; Albert M Osei; Lynn E Taylor; Asya M Cabral; Josiah D Rich Journal: Ann Intern Med Date: 2003-02-04 Impact factor: 25.391
Authors: Christopher Woodrell; Jeffrey Weiss; Andrea Branch; Donald Gardenier; Katherine Krauskopf; Natalie Kil; Harold Paredes; Kian Bichoupan; Keith Sigel Journal: J Addict Med Date: 2015 Sep-Oct Impact factor: 3.702
Authors: Monique A Foster; Jian Xing; Anne C Moorman; Joseph Boscarino; Stuart C Gordon; Mei Lu; Loralee Rupp; Mark A Schmidt; Connie M Trinacty; Fujie Xu; Scott D Holmberg; Philip R Spradling Journal: Dig Dis Sci Date: 2016-08-10 Impact factor: 3.199
Authors: R Ragusa; G Bertino; A Bruno; E Frazzetto; F Cicciu; G Giorgianni; L Lupo Journal: Health Qual Life Outcomes Date: 2018-01-17 Impact factor: 3.186
Authors: Kiren Mitruka; Karla Thornton; Susanne Cusick; Christina Orme; Ann Moore; Richard A Manch; Terry Box; Christie Carroll; Deborah Holtzman; John W Ward Journal: MMWR Morb Mortal Wkly Rep Date: 2014-05-09 Impact factor: 17.586